Ingredients supplier Sabinsa has named analytic testing firm Eurofins as its global testing partner for both raw materials and ingredients. Eurofins will also adapt some of Sabinsa’s own proprietary testing methods.
Photo © iStockphoto.com
Ingredients supplier Sabinsa Corp. (East Windsor, NJ) has named analytic testing firm Eurofins Scientific as its global testing partner, both for botanical raw materials as well as for Sabinsa’s own proprietary ingredients, including patented extracts and probiotics.
Per the agreement, Eurofins will also adapt some of Sabinsa’s proprietary testing methods to ensure that test methods are appropriate for Sabinsa’s own extracts and probiotic ingredients. In a press statement, Sabinsa explained that it is crucial for a lab to use appropriate test methods to test proprietary ingredients. It said that when a testing lab uses different testing methods from the manufacturer or other labs, inaccurate or “failed” test results can occur, wasting time and money in the process. It’s important for testing labs to be aware of which testing methods are appropriate, especially for a company’s unique, proprietary ingredients.
It’s with these issues in mind that Eurofins will test Sabinsa’s ingredients using Sabinsa’s own adapted, proprietary testing methods. These analytical methods were developed by Sami Labs, Sabinsa’s parent company, and have been validated using International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines for specificity, precision, and accuracy, Sabinsa said. Specifically, Sami Labs is sharing its testing methods for several of the company’s proprietary ingredients, including LactoSpore (for probiotic enumeration), Curcumin C3 Complex, BioPerine, and ForsLean, among others.
Anurag Pande, vice president of scientific affairs, Sabinsa, explained why the testing agreement comes at the right time, and how Sabinsa’s customers can benefit: “As you look at the supply chain, the need for third-party verification is increasing-but it becomes increasingly difficult analytically as new products come to market and test methods are not expanded in validation.”
He continued: “We believe it will simplify ID testing for our customers to have a lab available with this level of knowledge on testing our proprietary ingredients.”
Steve Mister on CRN's ongoing lawsuit against New York State
October 11th 2024Nutritional Outlook spoke to The Council for Responsible Nutrition's president and CEO, Steve Mister, at its annual meeting, Convergence '24. Mister discussed the latest in its ongoing lawsuit against NY State's law banning the sale of weight management and muscle building products to minors.